Marginal zone B cells are required for optimal humoral responses to allograft.

Autor: Gorbacheva V; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Fan R; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Gaudette B; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Baldwin WM 3rd; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Fairchild RL; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Valujskikh A; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: valujsa@ccf.org.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Sep 14. Date of Electronic Publication: 2024 Sep 14.

Discussion: “Report of the Committee on Standard Pipe and Pipe Threads, of the American Society of Mechanical Engineers” (Grinnell, Frederick, Bond, Geo. M., Schuhmann, George, Warren, B. H., and Baldwin, Wm. J., 1887, Trans. ASME, 8, pp. 29–40)

Autor: Smith, Oberlin, Kent, Wm., Stirling, Fowler, G. L., Wolff, A. R., Doane, W. H., Bond, Geo. M.

Publikováno v: Journal of Fluids Engineering; January 1887, Vol. 8 Issue: 1 p40-44, 5p

Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD.

Autor: Bin S; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero- University of Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum - University of Bologna, Bologna, Italy., Yoo M; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Molinari P; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gentile M; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Unità Operativa Nefrologia, Azienda-Ospedaliero University of Parma, Department of Medicine and Syrgery, University of Parma, Italy., Budge K; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Cantarelli C; Unità Operativa Nefrologia, Azienda-Ospedaliero University of Parma, Department of Medicine and Syrgery, University of Parma, Italy., Khan Y; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., La Manna G; Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero- University of Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum - University of Bologna, Bologna, Italy., Baldwin WM; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Dvorina N; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Cravedi P; Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gusella GL; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Publikováno v: JCI insight [JCI Insight] 2024 May 23; Vol. 9 (12). Date of Electronic Publication: 2024 May 23.

Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy.

Autor: Nevarez-Mejia J; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Jin YP; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Pickering H; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Parmar R; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Valenzuela NM; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Sosa RA; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Heidt S; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Fishbein GA; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA., Rozengurt E; Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, California, USA., Baldwin WM 3rd; Department of Inflammation & Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland Clinic, Ohio, USA., Fairchild RL; Department of Inflammation & Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland Clinic, Ohio, USA., Reed EF; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA. Electronic address: ereed@mednet.ucla.edu.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Mar; Vol. 24 (3), pp. 406-418. Date of Electronic Publication: 2023 Oct 29.

A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders.

Autor: Zhang L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA., Luo L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA., Chen JY; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA., Singh R; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Baldwin WM 3rd; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA., Fox DA; Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan, Ann Arbor, Michigan, USA., Lindner DJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Martin DF; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Caspi RR; Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA., Lin F; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Publikováno v: JCI insight [JCI Insight] 2023 Dec 08; Vol. 8 (23). Date of Electronic Publication: 2023 Dec 08.